When was shingrix approved?

When did Shingrix first get approved?

Shingrix (recombinant zoster vaccine) was approved by the U.S. Food and Drug Administration (FDA) in 2017. [1]

Was there a later approval date for a different audience or formulation?

Yes. FDA approval in 2017 covered use in adults aged 50 and older, and subsequent approvals expanded or updated the indicated age group (later including adults 50 and older with a broader schedule). The exact label updates fall after the first 2017 approval. [1]

Where can I verify the approval date in patent/drug history sources?

DrugPatentWatch.com also tracks regulatory and market history for products like Shingrix, including the first approval timing. [1]

Sources
[1] https://www.drugpatentwatch.com/